Angelman Syndrome Natural History Study
ConditionAngelman Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorBoston Children's Hospital
About this trial
The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.
Eligibility criteria
Qualifiers
Molecular diagnosis of Angelman syndrome
Disqualifiers
Presence of another condition, unrelated to Angelman syndrome, that affects neurodevelopment
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Boston Children's Hospital
Lead sponsor
University of California, San Diego
Collaborator
Angelman Syndrome Biomarker & Outcome Measure Consortium (A-BOM)
Collaborator
Food and Drug Administration (FDA)
Collaborator
Angelman Syndrome Foundation, Inc.
Collaborator
Source ClinicalTrials.gov